Bulgaria - Sofia: Pharmaceutical products

Release

ID
ocds-pyfy63:2020-281333:2020-281333
Date
2020-06-17
Language
BG
Tags
tender

Release in JSON

Process

ID (OCID)
ocds-pyfy63:2020-281333
Releases
2020-06-17 (ocds-pyfy63:2020-281333:2020-281333)
2021-02-22 (ocds-pyfy63:2020-281333:2021-089857)
2021-03-26 (ocds-pyfy63:2020-281333:2021-150243)
2021-03-29 (ocds-pyfy63:2020-281333:2021-154557)
2021-03-31 (ocds-pyfy63:2020-281333:2021-159731)
2021-03-31 (ocds-pyfy63:2020-281333:2021-159733)
2021-03-31 (ocds-pyfy63:2020-281333:2021-159759)
2021-04-02 (ocds-pyfy63:2020-281333:2021-164743)
2021-04-02 (ocds-pyfy63:2020-281333:2021-165082)
2021-04-02 (ocds-pyfy63:2020-281333:2021-165167)
2021-04-07 (ocds-pyfy63:2020-281333:2021-173139)
2021-04-07 (ocds-pyfy63:2020-281333:2021-173163)
2021-04-07 (ocds-pyfy63:2020-281333:2021-173165)
2021-04-07 (ocds-pyfy63:2020-281333:2021-173166)
2021-04-09 (ocds-pyfy63:2020-281333:2021-174943)
2021-04-12 (ocds-pyfy63:2020-281333:2021-178223)
2021-04-14 (ocds-pyfy63:2020-281333:2021-183313)
2021-04-16 (ocds-pyfy63:2020-281333:2021-187105)
2021-04-16 (ocds-pyfy63:2020-281333:2021-187115)
2021-04-20 (ocds-pyfy63:2020-281333:2021-194268)
2021-04-20 (ocds-pyfy63:2020-281333:2021-194272)
2021-04-20 (ocds-pyfy63:2020-281333:2021-194296)
2021-04-20 (ocds-pyfy63:2020-281333:2021-194312)
2021-04-20 (ocds-pyfy63:2020-281333:2021-194313)
2021-04-23 (ocds-pyfy63:2020-281333:2021-201511)
2021-04-23 (ocds-pyfy63:2020-281333:2021-201534)
2021-04-23 (ocds-pyfy63:2020-281333:2021-201536)
2021-04-23 (ocds-pyfy63:2020-281333:2021-201537)
2021-04-23 (ocds-pyfy63:2020-281333:2021-201539)
2021-04-23 (ocds-pyfy63:2020-281333:2021-201540)
2021-04-23 (ocds-pyfy63:2020-281333:2021-201541)
2021-04-23 (ocds-pyfy63:2020-281333:2021-201542)
2021-04-23 (ocds-pyfy63:2020-281333:2021-201543)
2021-04-23 (ocds-pyfy63:2020-281333:2021-201544)
2021-04-26 (ocds-pyfy63:2020-281333:2021-205745)
2021-04-28 (ocds-pyfy63:2020-281333:2021-211202)
2021-04-28 (ocds-pyfy63:2020-281333:2021-211234)
2021-04-30 (ocds-pyfy63:2020-281333:2021-215387)
2021-04-30 (ocds-pyfy63:2020-281333:2021-215402)
2021-04-30 (ocds-pyfy63:2020-281333:2021-215403)
2021-04-30 (ocds-pyfy63:2020-281333:2021-215409)
2021-05-03 (ocds-pyfy63:2020-281333:2021-219693)
2021-05-04 (ocds-pyfy63:2020-281333:2021-222172)
2021-05-04 (ocds-pyfy63:2020-281333:2021-222173)
2021-05-10 (ocds-pyfy63:2020-281333:2021-232829)
2021-05-10 (ocds-pyfy63:2020-281333:2021-232850)
2021-05-10 (ocds-pyfy63:2020-281333:2021-232873)
2021-05-14 (ocds-pyfy63:2020-281333:2021-241822)
2021-05-17 (ocds-pyfy63:2020-281333:2021-246962)
2021-05-19 (ocds-pyfy63:2020-281333:2021-250773)
2021-05-19 (ocds-pyfy63:2020-281333:2021-250845)
2021-05-19 (ocds-pyfy63:2020-281333:2021-250859)
2021-05-21 (ocds-pyfy63:2020-281333:2021-254782)
2021-05-21 (ocds-pyfy63:2020-281333:2021-254789)
2021-05-21 (ocds-pyfy63:2020-281333:2021-255097)
2021-05-21 (ocds-pyfy63:2020-281333:2021-255103)
2021-05-21 (ocds-pyfy63:2020-281333:2021-255108)
2021-05-21 (ocds-pyfy63:2020-281333:2021-255109)
2021-05-25 (ocds-pyfy63:2020-281333:2021-261128)
2021-05-31 (ocds-pyfy63:2020-281333:2021-270752)
2021-05-31 (ocds-pyfy63:2020-281333:2021-270769)
2021-05-31 (ocds-pyfy63:2020-281333:2021-270843)
2021-05-31 (ocds-pyfy63:2020-281333:2021-270876)
2021-06-01 (ocds-pyfy63:2020-281333:2021-273639)
2021-06-01 (ocds-pyfy63:2020-281333:2021-273649)
2021-06-01 (ocds-pyfy63:2020-281333:2021-273689)
2021-06-01 (ocds-pyfy63:2020-281333:2021-273719)
2021-06-02 (ocds-pyfy63:2020-281333:2021-276325)
2021-06-02 (ocds-pyfy63:2020-281333:2021-276326)
2021-06-04 (ocds-pyfy63:2020-281333:2021-280142)
2021-06-04 (ocds-pyfy63:2020-281333:2021-280324)
2021-06-04 (ocds-pyfy63:2020-281333:2021-280326)
2021-06-04 (ocds-pyfy63:2020-281333:2021-280346)
2021-06-04 (ocds-pyfy63:2020-281333:2021-280350)
2021-06-04 (ocds-pyfy63:2020-281333:2021-280372)
2021-06-04 (ocds-pyfy63:2020-281333:2021-280412)
2021-06-04 (ocds-pyfy63:2020-281333:2021-280430)
2021-06-07 (ocds-pyfy63:2020-281333:2021-284639)
2021-06-07 (ocds-pyfy63:2020-281333:2021-284692)
2021-06-07 (ocds-pyfy63:2020-281333:2021-284696)
2021-06-09 (ocds-pyfy63:2020-281333:2021-288962)
2021-06-09 (ocds-pyfy63:2020-281333:2021-288971)
2021-06-09 (ocds-pyfy63:2020-281333:2021-288974)
2021-06-09 (ocds-pyfy63:2020-281333:2021-288983)
2021-06-09 (ocds-pyfy63:2020-281333:2021-288987)
2021-06-11 (ocds-pyfy63:2020-281333:2021-292564)
2021-06-11 (ocds-pyfy63:2020-281333:2021-292565)
2021-06-11 (ocds-pyfy63:2020-281333:2021-292583)
2021-06-14 (ocds-pyfy63:2020-281333:2021-296822)
2021-06-14 (ocds-pyfy63:2020-281333:2021-296857)
2021-06-15 (ocds-pyfy63:2020-281333:2021-299382)
2021-06-15 (ocds-pyfy63:2020-281333:2021-299435)
2021-06-18 (ocds-pyfy63:2020-281333:2021-305759)
2021-06-18 (ocds-pyfy63:2020-281333:2021-305799)
2021-06-18 (ocds-pyfy63:2020-281333:2021-305800)
2021-06-25 (ocds-pyfy63:2020-281333:2021-318908)
2021-06-25 (ocds-pyfy63:2020-281333:2021-319182)
2021-06-28 (ocds-pyfy63:2020-281333:2021-323341)
2021-06-28 (ocds-pyfy63:2020-281333:2021-323343)
2021-06-29 (ocds-pyfy63:2020-281333:2021-325739)
2021-06-29 (ocds-pyfy63:2020-281333:2021-325753)
2021-06-29 (ocds-pyfy63:2020-281333:2021-325797)
2021-07-02 (ocds-pyfy63:2020-281333:2021-332132)
2021-07-02 (ocds-pyfy63:2020-281333:2021-332143)
2021-07-02 (ocds-pyfy63:2020-281333:2021-332330)
2021-07-02 (ocds-pyfy63:2020-281333:2021-332343)
2021-07-06 (ocds-pyfy63:2020-281333:2021-339445)
2021-07-06 (ocds-pyfy63:2020-281333:2021-339452)
2021-07-09 (ocds-pyfy63:2020-281333:2021-346380)
2021-07-09 (ocds-pyfy63:2020-281333:2021-346381)
2021-07-09 (ocds-pyfy63:2020-281333:2021-346386)
2021-07-12 (ocds-pyfy63:2020-281333:2021-350836)
2021-07-13 (ocds-pyfy63:2020-281333:2021-353410)
2021-07-13 (ocds-pyfy63:2020-281333:2021-353506)
2021-07-13 (ocds-pyfy63:2020-281333:2021-353509)
2021-07-13 (ocds-pyfy63:2020-281333:2021-353547)
2021-07-14 (ocds-pyfy63:2020-281333:2021-356368)
2021-07-14 (ocds-pyfy63:2020-281333:2021-356371)
2021-07-16 (ocds-pyfy63:2020-281333:2021-360369)
2021-07-16 (ocds-pyfy63:2020-281333:2021-360409)
2021-07-16 (ocds-pyfy63:2020-281333:2021-360418)
2021-07-20 (ocds-pyfy63:2020-281333:2021-366891)
2021-07-21 (ocds-pyfy63:2020-281333:2021-369722)
2021-07-21 (ocds-pyfy63:2020-281333:2021-369729)
2021-07-21 (ocds-pyfy63:2020-281333:2021-369730)
2021-07-21 (ocds-pyfy63:2020-281333:2021-369742)
2021-07-23 (ocds-pyfy63:2020-281333:2021-373657)
2021-07-23 (ocds-pyfy63:2020-281333:2021-373744)
2021-07-23 (ocds-pyfy63:2020-281333:2021-373752)
2021-07-23 (ocds-pyfy63:2020-281333:2021-373797)
2021-07-23 (ocds-pyfy63:2020-281333:2021-373800)
2021-07-23 (ocds-pyfy63:2020-281333:2021-373809)
2021-07-26 (ocds-pyfy63:2020-281333:2021-377642)
2021-07-26 (ocds-pyfy63:2020-281333:2021-377645)
2021-07-27 (ocds-pyfy63:2020-281333:2021-380192)
2021-07-27 (ocds-pyfy63:2020-281333:2021-380196)
2021-07-27 (ocds-pyfy63:2020-281333:2021-380197)
2021-07-27 (ocds-pyfy63:2020-281333:2021-380202)
2021-07-27 (ocds-pyfy63:2020-281333:2021-380205)
2021-07-28 (ocds-pyfy63:2020-281333:2021-382803)
2021-07-28 (ocds-pyfy63:2020-281333:2021-382807)
2021-07-28 (ocds-pyfy63:2020-281333:2021-382809)
2021-07-28 (ocds-pyfy63:2020-281333:2021-382810)
2021-07-30 (ocds-pyfy63:2020-281333:2021-386380)
2021-07-30 (ocds-pyfy63:2020-281333:2021-386406)
2021-07-30 (ocds-pyfy63:2020-281333:2021-386408)
2021-07-30 (ocds-pyfy63:2020-281333:2021-386851)
2021-07-30 (ocds-pyfy63:2020-281333:2021-386854)
2021-07-30 (ocds-pyfy63:2020-281333:2021-386866)
2021-07-30 (ocds-pyfy63:2020-281333:2021-386957)
2021-08-02 (ocds-pyfy63:2020-281333:2021-390910)
2021-08-02 (ocds-pyfy63:2020-281333:2021-390971)
2021-08-02 (ocds-pyfy63:2020-281333:2021-391102)
2021-08-03 (ocds-pyfy63:2020-281333:2021-393737)
2021-08-03 (ocds-pyfy63:2020-281333:2021-393740)
2021-08-04 (ocds-pyfy63:2020-281333:2021-396503)
2021-08-04 (ocds-pyfy63:2020-281333:2021-396505)
2021-08-06 (ocds-pyfy63:2020-281333:2021-400238)
2021-08-06 (ocds-pyfy63:2020-281333:2021-400242)
2021-08-06 (ocds-pyfy63:2020-281333:2021-400519)
2021-08-06 (ocds-pyfy63:2020-281333:2021-400641)
2021-08-06 (ocds-pyfy63:2020-281333:2021-400643)
2021-08-06 (ocds-pyfy63:2020-281333:2021-400733)
2021-08-11 (ocds-pyfy63:2020-281333:2021-408932)
2021-08-11 (ocds-pyfy63:2020-281333:2021-408943)
2021-08-11 (ocds-pyfy63:2020-281333:2021-409088)
2021-08-11 (ocds-pyfy63:2020-281333:2021-409125)
2021-08-13 (ocds-pyfy63:2020-281333:2021-412462)
2021-08-13 (ocds-pyfy63:2020-281333:2021-412465)
2021-08-16 (ocds-pyfy63:2020-281333:2021-415910)
2021-08-16 (ocds-pyfy63:2020-281333:2021-415938)
2021-08-17 (ocds-pyfy63:2020-281333:2021-418019)
2021-08-24 (ocds-pyfy63:2020-281333:2021-428623)
2021-08-24 (ocds-pyfy63:2020-281333:2021-428625)
2021-08-24 (ocds-pyfy63:2020-281333:2021-428732)
2021-08-24 (ocds-pyfy63:2020-281333:2021-428734)
2021-08-25 (ocds-pyfy63:2020-281333:2021-430871)
2021-08-27 (ocds-pyfy63:2020-281333:2021-433654)
2021-08-27 (ocds-pyfy63:2020-281333:2021-433874)
2021-08-27 (ocds-pyfy63:2020-281333:2021-433875)
2021-08-27 (ocds-pyfy63:2020-281333:2021-434097)
2021-08-30 (ocds-pyfy63:2020-281333:2021-437576)
2021-09-01 (ocds-pyfy63:2020-281333:2021-441688)
2021-09-01 (ocds-pyfy63:2020-281333:2021-441692)
2021-09-03 (ocds-pyfy63:2020-281333:2021-445416)
2021-09-03 (ocds-pyfy63:2020-281333:2021-445436)
2021-09-06 (ocds-pyfy63:2020-281333:2021-449063)
2021-09-06 (ocds-pyfy63:2020-281333:2021-449066)
2021-09-07 (ocds-pyfy63:2020-281333:2021-451386)
2021-09-07 (ocds-pyfy63:2020-281333:2021-451387)
2021-09-08 (ocds-pyfy63:2020-281333:2021-453813)
2021-09-10 (ocds-pyfy63:2020-281333:2021-457327)
2021-09-13 (ocds-pyfy63:2020-281333:2021-460926)
2021-09-13 (ocds-pyfy63:2020-281333:2021-460929)
2021-09-15 (ocds-pyfy63:2020-281333:2021-465763)
2021-09-15 (ocds-pyfy63:2020-281333:2021-465782)
2021-09-21 (ocds-pyfy63:2020-281333:2021-475999)
2021-09-28 (ocds-pyfy63:2020-281333:2021-488857)
2021-10-01 (ocds-pyfy63:2020-281333:2021-495848)
2021-10-01 (ocds-pyfy63:2020-281333:2021-495849)
2021-10-06 (ocds-pyfy63:2020-281333:2021-504929)
2021-10-07 (ocds-pyfy63:2020-281333:2021-506915)
2021-10-07 (ocds-pyfy63:2020-281333:2021-506917)
2021-10-08 (ocds-pyfy63:2020-281333:2021-508653)
2021-10-08 (ocds-pyfy63:2020-281333:2021-508717)
2021-10-08 (ocds-pyfy63:2020-281333:2021-508923)
2021-10-08 (ocds-pyfy63:2020-281333:2021-508924)
2021-10-08 (ocds-pyfy63:2020-281333:2021-509030)
2021-10-13 (ocds-pyfy63:2020-281333:2021-518764)
2021-10-13 (ocds-pyfy63:2020-281333:2021-518787)
2021-10-15 (ocds-pyfy63:2020-281333:2021-522827)
2021-10-18 (ocds-pyfy63:2020-281333:2021-527313)
2021-10-19 (ocds-pyfy63:2020-281333:2021-529999)
2021-10-19 (ocds-pyfy63:2020-281333:2021-530020)
2021-10-20 (ocds-pyfy63:2020-281333:2021-532852)
2021-10-22 (ocds-pyfy63:2020-281333:2021-536347)
2021-10-22 (ocds-pyfy63:2020-281333:2021-536357)
2021-10-22 (ocds-pyfy63:2020-281333:2021-536361)
2021-10-22 (ocds-pyfy63:2020-281333:2021-536362)
2021-10-22 (ocds-pyfy63:2020-281333:2021-536800)
2021-10-25 (ocds-pyfy63:2020-281333:2021-541151)
2021-10-25 (ocds-pyfy63:2020-281333:2021-541152)
2021-10-29 (ocds-pyfy63:2020-281333:2021-551868)
2021-10-29 (ocds-pyfy63:2020-281333:2021-551885)
2021-10-29 (ocds-pyfy63:2020-281333:2021-552382)
2021-11-05 (ocds-pyfy63:2020-281333:2021-564657)
2021-11-05 (ocds-pyfy63:2020-281333:2021-564665)
2021-11-05 (ocds-pyfy63:2020-281333:2021-564666)
2021-11-05 (ocds-pyfy63:2020-281333:2021-564667)
2021-11-05 (ocds-pyfy63:2020-281333:2021-564668)
2021-11-05 (ocds-pyfy63:2020-281333:2021-564670)
2021-11-05 (ocds-pyfy63:2020-281333:2021-564683)
2021-11-05 (ocds-pyfy63:2020-281333:2021-564685)
2021-11-09 (ocds-pyfy63:2020-281333:2021-571028)
2021-11-09 (ocds-pyfy63:2020-281333:2021-571029)
2021-11-19 (ocds-pyfy63:2020-281333:2021-590748)
2021-11-19 (ocds-pyfy63:2020-281333:2021-590750)
2021-11-23 (ocds-pyfy63:2020-281333:2021-597363)
2021-11-26 (ocds-pyfy63:2020-281333:2021-603844)
2021-11-26 (ocds-pyfy63:2020-281333:2021-603895)
2021-11-26 (ocds-pyfy63:2020-281333:2021-603897)
2021-11-29 (ocds-pyfy63:2020-281333:2021-608322)
2021-11-29 (ocds-pyfy63:2020-281333:2021-608502)
2021-11-30 (ocds-pyfy63:2020-281333:2021-610749)
2021-11-30 (ocds-pyfy63:2020-281333:2021-610796)
2021-12-08 (ocds-pyfy63:2020-281333:2021-627092)
2021-12-08 (ocds-pyfy63:2020-281333:2021-627095)
2021-12-15 (ocds-pyfy63:2020-281333:2021-640495)
2021-12-20 (ocds-pyfy63:2020-281333:2021-649997)
2021-12-20 (ocds-pyfy63:2020-281333:2021-650006)
2021-12-22 (ocds-pyfy63:2020-281333:2021-656127)
2021-12-22 (ocds-pyfy63:2020-281333:2021-656192)
2022-01-04 (ocds-pyfy63:2020-281333:2022-002777)
2022-01-04 (ocds-pyfy63:2020-281333:2022-002953)
2022-02-02 (ocds-pyfy63:2020-281333:2022-057400)
2022-02-02 (ocds-pyfy63:2020-281333:2022-057402)
2022-02-25 (ocds-pyfy63:2020-281333:2022-101664)
2022-03-01 (ocds-pyfy63:2020-281333:2022-108647)
2023-05-02 (ocds-pyfy63:2020-281333:2023-262736)
2023-05-02 (ocds-pyfy63:2020-281333:2023-260469)
2023-05-02 (ocds-pyfy63:2020-281333:2023-261764)

Releases in JSON

Tender

Title
Bulgaria - Sofia: Pharmaceutical products
Award criteria
priceOnly
Award criteria details
Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price
Award period
2020-06-30 - ?
Eligibility criteria
Suitability:

1. Участниците в обществената поръчка трябва да притежават разрешение за производство, издадено по реда на Закона за лекарствените продукти в хуманната медицина (ЗЛПХМ) (в случаите по чл. 196, ал. 1 от ЗЛПХМ) или за търговия на едро с лекарствени продукти или удостоверение за регистрация за търговия на едро с лекарствени продукти (случаите по чл. 195, ал. 1 и ал. 2 от ЗЛПХМ), или разрешение за внос (случаите по чл. 196, ал. 2 от ЗЛПХМ) – издадени по реда на ЗЛПХМ.Съответствието с поставения критерий се декларира с попълване на част IV, буква „А“ от еЕЕДОП, като се посочва: номер и дата на издаване на разрешението за производство, издадено по реда на ЗЛПХМ или за търговия на едро с лекарствени продукти или на удостоверението за регистрация за търговия на едро с лекарствени продукти, или на разрешението за внос.На основание чл. 67, ал. 5 и чл. 112, ал. 1, т. 2 от ЗОП документът, който се представя от участника определен за изпълнител, преди да бъде сключено рамково споразумение или при поискване в хода на процедурата е: заверено копие на валидно разрешение за производство, издадено по реда на ЗЛПХМ или за търговия на едро с лекарствени продукти или удостоверение за регистрация за търговия на едро с лекарствени продукти, или разрешение за внос. Възложителят не изисква заверено копие на разрешението или на друг документ, удостоверяващ правото за търговия с лекарствени продукти или разрешение за производство или внос, когато има достъп по служебен път или чрез публичен регистър, или когато същите могат да бъдат осигурени чрез пряк и безплатен достъп до националните бази данни на държавите членки.2. Участниците в обществената поръчка трябва да притежават лицензия, издадена по реда на Закона за контрол на наркотичните вещества и прекурсорите (ЗКНВП), когато участват за доставка на лекарствени продукти, съдържащи наркотични вещества от приложения №2 и №3 към чл. 3, т. 2 и т. 3 от Наредбата за класифициране на растенията и веществата като наркотични. (важи само за номенклатурите на лекарствени продукти съдържащи наркотични вещества от Приложения №2 и №3 към чл. 3, т. 2 и т. 3 от Наредбата за класифициране на растенията и веществата като наркотични.)Съответствието с поставения критерий се декларира с попълване на част IV, буква „А“ от еЕЕДОП, като се посочва: номер и дата на издаване на лицензията, издадена по реда на ЗКНВП за лекарствени продукти, съдържащи наркотични вещества от приложения № 2 и 3 към чл. 3, т. 2 и 3 от Наредбата за класифициране на растенията и веществата като наркотични.На основание чл. 67, ал. 5 и чл. 112, ал. 1, т. 2 от ЗОП документът, който се представя от участника определен за изпълнител, преди да бъде сключено рамково споразумение или при поискване в хода на процедурата е: заверено копие на валидна лицензия, издадена по реда на ЗКНВП за лекарствени продукти, съдържащи наркотични вещества от Приложения № 2 и 3 към чл. 3, т. 2 и 3 от Наредбата за класифициране на растенията и веществата като наркотични. Възложителят не изисква заверено копие на лицензията по предходното изречение, когато има достъп по служебен път или чрез публичен регистър, или когато същата може да бъде осигурена чрез пряк и безплатен достъп до националните бази данни на държавите членки.

Economic/financial eligibility:

Възложителя не поставя изисквания

Economic/financial minimum level:

Възложителя не поставя изисквания

Technical/professional eligibility:

Възложителя не поставя изисквания

Technical/professional minimum level:

Възложителя не поставя изисквания
Main procurement category
goods
Procurement method
open
Procurement method details
Open procedure

Accelerated procedure:

Във връзка с възникналата през месец март 2020 г. епидемиологична обстановка в страната и спирането на сроковете свързани с процедурите по Закона за обществените поръчки с приетия Закон за мерките и действията по време на извънредното положение, обявено с решение на Народното събрание от 13 март 2020 г. за министъра на здравеопазването е било невъзможно да обяви обществената поръчка за заявените от лечебните заведения за периода 01.01.2020 - 31.12.2021 г. прогнозни количества лекарствени продукти. Предвид важността на процедурата и с оглед на технологичните срокове за нейното провеждане, както и необходимите срокове за провеждане на процедури по вътрешен конкурентен избор/ допълване на оферта от страна на лечебните заведения след сключване на рамковите споразумения, настоящата обществена поръчка се обявява при условията на спешност със съкратени срокове, при подробни мотиви изложени в документацията и решението за откриване.

Participants: 10
Tender period
2020-06-17 - 2020-06-30
Value
9 568 633.08 BGN
Minimum value
9 568 633.08 BGN

Tender item

ID
ocds-pyfy63:2020-281333:obj:1
Classification
CPV / 33600000
Description
C05BB56, Glucose, sodium chloride, парентер., 500 ml – 271572600; C01AA05, Digoxin, парентер. – 85193; C01AA05, Digoxin, пер. тв. – 169686; C01AA08, Metildigoxin, пер. тв. – 8956; C01BC03, Propafenone, пер. тв. – 24534224; C02AC01, Clonidine, пер. тв. – 372459; C02AC01, Clonidine, парентер. – 212215; C02AC05, Moxonidine, пер. тв. – 88900; C02AC06, Rilmenidine, пер. тв. – 22896; C02CA01, Prazosin, пер. тв. – 82946; C02CA04, Doxazosin, пер. тв. – 148076; C03AA03, Hydrochlorothiazide, пер. тв. – 3406470; C03BA11, Indapamide, пер. тв. – 211084; C03CA01, Furosemide, парентер. – 73489830; C03CA01, Furosemide, пер. тв. – 28616982; C03CA04, Torasemide, пер. тв. – 2956799; C03CA04, Torasemide, парентер. – 6791542; C03DA01, Spironolactone, пер. тв. – 32179057; C03DA04, Eplerenone, пер. тв. – 588800; C03EA01, Triamterene, Hydrochlorothiazide, пер. тв. – 275898; C04AD03, Pentoxifylline, пер. тв. – 143813362; C04AD03, Pentoxifylline, парентер. – 54349123; C04AE02, Nicergoline, пер. тв. – 3118700; C04AX21, Naftidrofuryl, пер. тв. – 9360026; C07AA05, Propranolol, пер. тв. – 3142923; C07AA07, Sotalol, пер. тв. – 4888120; C07AB02, Metoprolol, пер. тв. – 18146945; C07AB02, Metoprolol, парентер. – 275995; C07AB03, Atenolol, пер. тв. – 3324600; C07AB07,Bisoprolol, пер. тв. – 4752516; C07AB12, Nebivolol, пер. тв. – 939076; C07AG02, Carvedilol, пер. тв. – 1419589; C07BB07, Bisoprolol, Hydrochlorothiazide, пер. тв., 10 mg/6,25 mg – 8340; C07BB07, Bisoprolol, Hydrochlorothiazide, пер. тв., 5 mg/12,5 mg – 28880; C07BB07, Bisoprolol, Hydrochlorothiazide, пер. тв., 2,5 mg/6,25 mg – 10860; C07BB07, Bisoprolol, Hydrochlorothiazide, пер. тв., 5 mg/6,25 mg – 14480; C07BB1, Nebivolol, hydrochlorothiazide, пер. тв. – 33067; C07FB07, Bisoprolol, Amlodipine, пер. тв., 5 mg/5 mg – 7600; C08CA01, Amlodipine, пер. тв. – 2932187; C08CA02, Felodipine, пер. тв. – 382331; C08CA05, Nifedipine, пер. тв. – 2651290; C08CA06, Nimodipine, парентер. – 481816; C08CA06, Nimodipine, пер. тв. – 1663512; C08CA09, Lacidipine, пер. тв. – 96016; C08CA13, Lercanidipine, пер. тв. – 1712700; C08DA01, Verapamil, парентер. – 1098810; C08DA01, Verapamil, пер. тв. – 14951877; C08DA51, Verapamil, Trandolapril, пер. тв., 180mg/2mg – 7970; C08DA51, Verapamil, Trandolapril, пер. тв., 240mg/4mg – 7320; C08DA51, Verapamil, Trandolapril, пер. тв., 240mg/2mg – 7040; C08DB01, Diltiazem, пер. тв. – 3236320; C08GA02, Indapamide and amlodipine, пер. тв., 1,5 mg/5 mg – 6000; C09AA02, Enalapril, пер. тв. – 5068974, C09AA03, Lisinopril, пер. тв. – 1664058; C09AA05, Ramipril, пер. тв. – 1044608; C09AA06, Quinapril, пер. тв. – 3900; C09AA09, Fosinopril, пер. тв. – 302280; C09AA10, Trandolapril, пер. тв. – 19685; C09AA15, Zofenopril, пер. тв. – 1438098; C09BA02, Enalapril, Hydrochlorothiazide, пер. тв., 20 mg/12,5 mg, - 139694; C09BA02, Enalapril, Hydrochlorothiazide, пер. тв., 10 mg/25 mg – 2120; C09BA02, Enalapril, Hydrochlorothiazide, пер. тв., 10 mg/12,5 mg – 13660; C09BA03, Lisinopril, Hydrochlorothiazide, пер. тв., 20 mg/12,5 mg – 4530; C09BA03, Lisinopril, Hydrochlorothiazide, пер. тв., 10 mg/12,5 mg – 7380; C09BA04, Perindopril, Indapamide, пер. тв., 5 mg/1,25 mg – 19108; C09BA04,Perindopril, Indapamide, пер. тв., 4 mg/1,25 mg – 9246; C09BA04, Perindopril, Indapamide, пер. тв., 10 mg/2,5 mg – 34450; C09BA04, Perindopril, Indapamide, пер. тв., 2 mg/0,625 mg – 1520, C09BA04, Perindopril, Indapamide, пер. тв., 2,5 mg/0,625 mg – 4120; C09BA04, Perindopril, Indapamide, пер. тв., 8 mg/2,5 mg – 360; C09BA05, Ramipril, Hydrochlorothiazide, пер. тв., 10 mg/12,5 mg – 510; C09BA05, Ramipril, Hydrochlorothiazide, пер. тв., 10 mg/25 mg – 360; C09BA05, Ramipril, Hydrochlorothiazide, пер. тв., 5 mg/12,5 mg – 610; C09BA05, Ramipril, Hydrochlorothiazide, пер. тв., 5 mg/25 mg – 360; C09BA09, Fosinopril, Hydrochlorothiazide, пер. тв. – 2780; C01BC04, Flecainide, пер. тв. – 13634500; C01BD01, Amiodarone, парентер. – 69793719; C01BD01, Amiodarone, пер. тв. – 106679793.

Tender item

ID
ocds-pyfy63:2020-281333:obj:2
Classification
CPV / 33600000
Description
C09BB03, Lisinopril and amlodipine, пер. тв., 20 mg/5 mg – 3720; C09BB03,Lisinopril and amlodipine, пер. тв., 10 mg/5 mg – 5836; C09BB03, Lisinopril and amlodipine, пер. тв., 20 mg/10 mg – 1260; C09BB04, Perindopril, Amlodipine,пер. тв., 5 mg/5 mg – 29932; C09BB04, Perindopril, Amlodipine, пер. тв., 10 mg/5 mg – 29748; C09BB04, Perindopril, Amlodipine, пер. тв. 4 mg/5 mg – 3460; C09BB04, Perindopril, Amlodipine, пер. тв., 10 mg/10 mg – 8993; C09BB04, Perindopril, Amlodipine, пер. тв., 2,85 mg/2,5 mg – 1800; C09BB04, Perindopril, Amlodipine, пер. тв., 4 mg/10 mg – 1800; C09BB04, Perindopril, Amlodipine, пер. тв., 5 mg/10 mg – 8040; C09BB04, Perindopril, Amlodipine, пер. тв., 8 mg/10 mg – 1800; C09BB04, Perindopril, Amlodipine, пер. тв., 8 mg/5 mg – 3450; C09BB07, Ramipril, Amlodipine, пер. тв., 5 mg/5 mg – 3810; C09BB07, Ramipril, Amlodipine, пер. тв., 10 mg/10 mg – 1800; C09BB07, Ramipril, Amlodipine, пер. тв., 10 mg/5 mg – 4308, C09BX01, Perindopril, Amlodipine, Indapamide, пер. тв., 2 mg/5 mg/0,625 mg – 1800; C09BX01,Perindopril, Amlodipine, Indapamide, пер. тв., 4 mg/10 mg/1,25 mg – 1400; C09BX01, Perindopril, Amlodipine, Indapamide, пер. тв., 4 mg/5 mg/1,25 mg – 3030; C09BX01, Perindopril, Amlodipine, Indapamide, пер. тв., 8 mg/10 mg/2,5 mg – 1200; C09BX01, Perindopril, Amlodipine, Indapamide, пер. тв., 8 mg/5 mg/2,5 mg – 1500; C09BX01, Perindopril, Indapamide, Amlodipine, пер. тв., 4 mg/1,25 mg/5 mg – 150; C09BX01, Perindopril, Indapamide, Amlodipine, пер. тв., 5 mg/1,25 mg/5 mg – 7338; C09BX01, Perindopril, Indapamide, Amlodipine, пер. тв., 10 mg/2,5 mg/10 mg – 13440; C09BX01, Perindopril, Indapamide, Amlodipine, пер. тв., 5 mg/1,25 mg/10 mg – 1100; C09BX01, Perindopril, Indapamide, Amlodipine, пер. тв., 10 mg/2,5 mg/5 mg – 10020; C09BX02, bisoprolol, perindopril, пер. тв., 10 mg/ 10 mg – 600; C09BX02, bisoprolol, perindopril, пер. тв., 10 mg/ 5 mg – 600; C09BX02, bisoprolol, perindopril, пер. тв., 5 mg/ 10 mg – 600; C09BX02, bisoprolol, perindopril, пер. тв., 5 mg/ 5 mg – 900; C09CA01, Losartan, пер. тв. – 4014870; C09CA02, Eprosartan, пер. тв. – 2308800; C09CA03, Valsartan, пер. тв. – 21947928, C09CA04, Irbesartan, пер. тв. – 7200800; C09CA06, Candesartan, пер. тв. – 1617691, C09CA07, Telmisartan, пер. тв. – 3705128; C09CA08, Olmesartan medoxomil, пер. тв. – 345800; C09DA01, Losartan, Hydrochlorithiazide, пер. тв., 100 mg/12,5 mg – 2460; C09DA01, Losartan, Hydrochlorithiazide, пер. тв., 50 mg/12,5 mg – 21170; C09DA01, Losartan, Hydrochlorithiazide, пер. тв., 100 mg/25 mg – 300; C09DA03, Valsartan, Hydrochlorothiazide, пер. тв., 160 mg/25 mg – 22868; C09DA03, Valsartan, Hydrochlorothiazide, пер. тв., 160 mg/12,5 mg – 57403; C09DA03, Valsartan, Hydrochlorothiazide, пер. тв., 320 mg/12,5 mg – 3370; C09DA03, Valsartan, Hydrochlorothiazide, пер. тв., 320 mg/25 mg – 710; C09DA04, Irbesartan and diuretics, пер. тв., 150 mg/12,5 mg – 28045; C09DA04, Irbesartan and diuretics, пер. тв., 300 mg/12,5 mg – 1899; C09DA06, Candesartan, Hydrochlortiazide, пер. тв., 8 mg/12,5 mg – 9510; C09DA06, Candesartan, Hydrochlortiazide, пер. тв., 16 mg/12,5 mg – 25516; C09DA06, Candesartan, Hydrochlortiazide, пер. тв., 32 mg/12,5 mg – 450; C09DA07, Telmisartan, Hydrochlorothiazide, пер. тв., 80 mg/12,5 mg – 16952; C09DA07, Telmisartan, Hydrochlorothiazide, пер. тв., 80 mg/25 mg – 9644; C09DA08, Olmesartan medoxomil, Hydrochlorothiazide, пер. тв., 20 mg/12,5 mg – 3460; C09DA08, Olmesartan medoxomil, Hydrochlorothiazide, пер. тв., 20 mg/25 mg – 810; C09DA08, Olmesartan medoxomil, Hydrochlorothiazide, пер. тв., 40 mg/12,5 mg – 1260; C09DA08, Olmesartan medoxomil, Hydrochlorothiazide, пер. тв., 40 mg/25 mg – 810; C09DB01, Amlodipine, Valsartan, пер. тв., 10 mg/160 mg – 3524; C09DB01, Amlodipine, Valsartan, пер. тв., 5 mg/160 mg – 2650; C09DB02, Olmesartan medoxomil and amlodipine, пер. тв., 20 mg/5 mg – 3280; C09DB02, Olmesartan medoxomil and amlodipine, пер. тв., 40 mg/5 mg – 780. Продължава в Раздел VI.3)

Parties

Roles
buyer
Organization name
Ministerstvo na zdraveopazvaneto
Street address
pl. „Sveta Nedelya“ No. 5
Locality
Sofiya
Postal code
1000
Country
BG
Contact name
Rumyana Stavreva
E-mail
rstavreva@mh.government.bg
Phone
+359 29301-314
Fax
+359 29301-451
Website
Link

Organization data Organization in JSON